Transcatheter Tricuspid Valve Interventions Medical Policy
Customize your policy alerts
Sign up for Health-New-England Policy UM1003POL alerts
Get alerted when Policy UM1003POL changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity determinations for transcatheter tricuspid valve repair, replacement, and caval valve implantation for Health New England Commercial, Medicare Advantage, and Medicaid members.
Medicare coverage for transcatheter tricuspid valve replacement and transcatheter edge-to-edge repair now uses adopted InterQual criteria together with the applicable Medicare National Coverage Determinations.
Commercial and Medicaid criteria were added for transcatheter tricuspid valve replacement or repair when severe symptomatic tricuspid regurgitation persists despite optimal medical therapy and the heart team determines that open-heart surgery presents high risk.
Transcatheter edge-to-edge repair for tricuspid regurgitation is addressed through the applicable Medicare National Coverage Determination and adopted criteria.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.